Executive Summary Cetuximab Market : The global cetuximab market size was valued at USD 1.13 billion in 2024 and is expected to reach USD 1.85 billion by 2032, at a CAGR of 6.36% during the forecast period. The Cetuximab Market report has all the details about market analysis, market definition, market segmentation, key development areas,...

Key Drivers Impacting Executive Summary Cetuximab Market Size and Share The global cetuximab market size was valued at USD 1.13 billion in 2024 and is expected to reach USD 1.85 billion by 2032, at a CAGR of 6.36% during the forecast period The credible Cetuximab Marketreport comprises of various segments linked to Cetuximab Market industry and...

"Executive Summary: Intravenous (IV) Equipment Market Size and Share by Application & Industry CAGR Value The global intravenous (IV) equipment market size was valued at USD 15.86 billion in 2024 and is expected to reach USD 26.64 billion by 2032, at a CAGR of 6.70% during the forecast period For the growth of business, Intravenous (IV) Equipment...

The global companion diagnostics (CDx) development market was valued at USD 845.99 million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2034, driven by the increasing integration of biomarker-driven therapies into oncology and precision medicine pipelines. This growth trajectory reflects rising demand for diagnostic tools that can identify...

"Executive Summary Nivolumab Market Size and Share Across Top Segments CAGR Value The global Nivolumab market was valued at USD 1.71 Billion in 2024 and is expected to reach USD 3.20 Billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.20%, primarily driven by the rising prevalence of cancer and increasing adoption of immunotherapy as...

This Nivolumab market report has been prepared by considering several fragments of the present Nivolumab market and the upcoming market scenario. The market insights gained through this market research analysis report facilitate a clearer understanding of the market landscape, issues that may interrupt in the future, and ways to position a brand excellently. It consists of most-detailed...

Market Overview / Summary The global non-small cell lung cancer market size was valued at USD 34.14 billion in 2024, growing at a CAGR of 14.3% from 2025–2034. Rising global incidence of non-small cell lung cancer (NSCLC), coupled with growing adoption of liquid biopsies and multiplexed platforms is enabling non-invasive monitoring in NSCLC. The adoption of next-generation diagnostics,...

"Executive Summary Point-of-Care Coagulation Testing Devices Market Opportunities by Size and Share CAGR Value  Data Bridge Market Research analyses that the point-of-care coagulation testing devices market is growing at a CAGR of 5.21% in the forecast period of 2022-2029 and is likely to reach USD 1,331.254 million in 2029. Point-of-Care Coagulation Testing Devices Market...